Interbody fusion deVice based on 3D printing and preparation method of deVice

An intervertebral fusion device and 3D printing technology, applied in the field of biomedicine, can solve the problems of inability to modify biological properties of materials, limitations of molding process, waste of raw materials, etc., achieve excellent biocompatibility and chemical stability, and avoid stress Covering and loosening, to achieve full use of the effect

Active Publication Date: 2018-10-19
MEDPRIN REGENERATIVE MEDICAL TECH
View PDF8 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

PEEK fusion cage has better mechanical properties, but because it is a biologically inert material, after implantation in the intervertebral space, the upper and lower vertebral bodies can only be connected by the bone graft in the cage cavity, and the fusion cage itself cannot form osseointegration with new bone. Easy to cause loosening and displacement in the later stage of implantation
At present, the domestic production mainly uses rods through machining and forming, while many foreign countries use thermoplastic processing and forming. The former causes waste of raw materials, and the latter's forming process is limited by molds, making it difficult to carry out structural improvements. Patient Profile Personalized
[0005] The existing fusion cage itself cannot form an osseointegration with the new bone, and it is easy to cause loosening and displacement problems in the later stage of implantation
The traditional molding process cannot modify the material during the molding process to improve its biological properties

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] In this embodiment, PEEK raw material is used as the printing material of the first nozzle, and the mixed material of polycaprolactone and hydroxyapatite is used as the printing material of the second nozzle. Both nozzles adopt the melt extrusion method to 3D print the lumbar fusion device.

[0057] Dissolve polycaprolactone in dioxane solvent, and add hydroxyapatite powder with a particle size of 10-100 μm to it, stir evenly, freeze-dry to remove dioxane, and obtain polycaprolactone and hydroxyphosphorus A mixture of limestone in which the mass ratio of polycaprolactone to hydroxyapatite is 1:1. Add PEEK to the silo of the first nozzle, raise the temperature to 380°C until the PEEK melts; add the mixture of polycaprolactone and hydroxyapatite to the silo of the second nozzle, raise the temperature to 220°C until the mixture melts. The temperature of the molding room is kept at normal temperature, and the printing is carried out alternately according to the established ...

Embodiment 2

[0065] In this embodiment, the PEEK raw material is used as the printing material of the first nozzle, and the mixed material of polylactic acid and bioglass is used as the printing material of the second nozzle. The first nozzle is printed by melt extrusion, and the second nozzle is printed by solvent dissolution and low-temperature molding to prepare the lumbar fusion device.

[0066] Polylactic acid was dissolved in dioxane solvent, and bioglass powder with a particle size of 20-200 nm was added to it, and stirred to form a uniform slurry. The concentration of polylactic acid in the slurry was 80 wt.%, and the mass ratio of polylactic acid to bioglass was 1:0.05.

[0067] Add PEEK to the silo of the first nozzle, and raise the temperature to 420°C until the PEEK melts; add the slurry of polylactic acid and bioglass to the silo of the second nozzle, and keep it at room temperature. The forming room received a temperature of -10°C, and alternately printed according to the es...

Embodiment 3

[0076] In this embodiment, the PEKK raw material is used as the printing material of the first nozzle, and the mixed material of gelatin and calcium sulfate is used as the printing material of the second nozzle. The first nozzle is printed by melt extrusion, and the second nozzle is printed by solvent dissolution and low-temperature molding to prepare the cervical fusion cage.

[0077] Dissolve gelatin in deionized water at 40°C, add calcium sulfate powder with a particle size of 500nm to 100μm, and stir to form a uniform slurry. The gelatin concentration in the slurry was 20 wt.%, and the mass ratio of gelatin to calcium sulfate was 1:5.

[0078] Add PEKK to the silo of the first nozzle, raise the temperature to 500°C until PEKK melts; add the slurry of gelatin and calcium sulfate to the silo of the second nozzle,

[0079] The temperature of the second nozzle is kept at about 40°C. The forming room received a temperature of 10°C, and alternately printed according to the est...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
concentrationaaaaaaaaaa
Login to view more

Abstract

The inVention discloses an interbody fusion deVice based on 3D printing and a preparation method of the deVice. By adopting polyaryletherketone series materials as basic raw materials, adopting a mixture of degradable high-molecular materials and actiVated osteogenesis powder as an auxiliary raw material and utilizing a dual-sprayer extrusion-type 3D printing technology, the interbody fusion deVice is prepared. The interbody fusion deVice is of a hollow three-dimensional through structure, wherein the Volume ratio of the basic raw materials to the auxiliary raw material is (1:0.01)-(1:1). Thesurface of the interbody fusion deVice is proVided with cell identification sites, and therefore the interbody fusion deVice is applicable to a micro enVironment for cell adhesion and new bone deposition, so that the combination capability between the interbody fusion deVice and new bones is improVed. MoreoVer, with degradation of the degradable high-molecular materials, spaces of porous structures can be formed, gradual growth of the new bones into the spaces is facilitated to achieVe close combination between the interbody fusion body and bone tissue, and loosening and displacement of the interbody fusion deVice cannot occur.

Description

technical field [0001] The invention relates to the field of biomedical technology, and more specifically, to a 3D printed intervertebral fusion device and a preparation method thereof. Background technique [0002] At present, my country's aging population is gradually deepening, and the spinal degenerative diseases it brings have become common and frequently-occurring diseases that plague human beings in today's society. Degenerative spondylosis leads to intervertebral disc herniation, vertebral segmental instability, and nerve root compression symptoms caused by osteophyte formation, which seriously affects the work and life of patients. Once medication and physical conservative treatment fail, surgical treatment is often the final choice. Many scholars divide the essence of modern spinal surgery into four parts: decompression, fusion, orthopedics, and internal fixation. Intervertebral fusion combined with internal fixation is an effective means of modern clinical treatm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61F2/44A61L27/02A61L27/10A61L27/12A61L27/18A61L27/20A61L27/22A61L27/50A61L27/54A61L27/58B33Y10/00B33Y70/00
CPCA61F2/30942A61F2/4455A61F2002/30062A61F2002/30985A61L27/025A61L27/10A61L27/12A61L27/18A61L27/20A61L27/222A61L27/50A61L27/54A61L27/58A61L2300/414A61L2430/02B33Y10/00B33Y70/00C08L61/16C08L67/04C08L5/12
Inventor 张婧邓坤学袁玉宇
Owner MEDPRIN REGENERATIVE MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products